CBIA Stock: Canopus BioPharma Incorporated Stock Price, Analysis & Insights
Get live CBIA stock price $0.00, comprehensive Canopus BioPharma Incorporated stock analysis, charts, news, and expert forecast. Real-time CBIA stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Canopus BioPharma Incorporated operates as a pharmaceutical research firm, delivering a range of therapeutic products and diagnostic assay methods to individuals afflicted by infectious diseases, cancer, and addiction. The company's diverse product p...
Company Information
- CEO
- Patrick T. Prendergast
- Sector
- Financial Services
- Industry
- Shell Companies
- Employees
- N/A
Contact Information
- Website
- https://www.blueheaven.cafe
- Address
- 233 Wilshire Boulevard
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Financial Services sector with established market position
✓ Higher growth potential with elevated volatility (Beta: 8.17)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Canopus BioPharma Incorporated shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Financial Services may affect company performance
- ⚠Past performance does not guarantee future results for Canopus BioPharma Incorporated
- ⚠Investors should consider how Canopus BioPharma Incorporated fits within their overall portfolio allocation
Market Cap
455.07K
Beta
8.17
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare CBIA with peer companies:
- Price
- $0.00
- Market cap
- 192.17K
- Price
- $1.68
- Market cap
- 714.01K
- Price
- $0.00
- Market cap
- 1.86M
- Price
- $0.00
- Market cap
- 2.33K
- Price
- $0.10
- Market cap
- 2.17M
- Price
- $0.00
- Market cap
- 193.64K
- Price
- $0.00
- Market cap
- 498.50K
- Price
- $0.00
- Market cap
- 474.57K
- Price
- $0.00
- Market cap
- 298
- Price
- $1.00
- Market cap
- 400.44K
About Financial Services Sector
The Financial Services sector includes companies that provide banking, insurance, investment, and other financial services to consumers and businesses.